Peter M.L. Teo

3.7k total citations · 1 hit paper
34 papers, 2.9k citations indexed

About

Peter M.L. Teo is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Peter M.L. Teo has authored 34 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Otorhinolaryngology, 16 papers in Surgery and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Peter M.L. Teo's work include Head and Neck Cancer Studies (21 papers), Head and Neck Surgical Oncology (12 papers) and Advanced Radiotherapy Techniques (6 papers). Peter M.L. Teo is often cited by papers focused on Head and Neck Cancer Studies (21 papers), Head and Neck Surgical Oncology (12 papers) and Advanced Radiotherapy Techniques (6 papers). Peter M.L. Teo collaborates with scholars based in China, Hong Kong and United States. Peter M.L. Teo's co-authors include Anthony T.�C. Chan, Benny Zee, Ricky Ming-chun Chau, Peter H.K. Choi, Michael Kam, W. H. Kwan, K.Y. Cheung, Joyce Suen, Ka‐Fai To and Dolly P. Huang and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Peter M.L. Teo

34 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients

2007 544 citations Michael K. M. Kam, Sing-Fai Leung et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter M.L. Teo China	24	1.9k	1.2k	1.1k	978	494	34	2.9k
Sing-Fai Leung Hong Kong	21	1.2k 0.6×	755 0.6×	652 0.6×	807 0.8×	205 0.4×	23	2.2k
Johnny Kao United States	31	792 0.4×	827 0.7×	1.2k 1.1×	1.0k 1.1×	417 0.8×	76	2.9k
François Janot France	35	2.0k 1.1×	1.9k 1.6×	912 0.8×	1.5k 1.5×	164 0.3×	146	3.5k
Antoine Lusinchi France	23	1.1k 0.6×	1.2k 1.0×	859 0.8×	745 0.8×	219 0.4×	34	2.2k
Ding-Jen Lee United States	8	2.1k 1.1×	1.5k 1.3×	1.1k 1.0×	878 0.9×	116 0.2×	12	2.8k
Gordon K.�H. Au Hong Kong	28	2.4k 1.2×	1.8k 1.5×	1.1k 1.0×	1.4k 1.4×	193 0.4×	38	4.3k
Y.F. Poon China	23	1.2k 0.6×	972 0.8×	637 0.6×	1.2k 1.2×	106 0.2×	27	2.3k
Yungan Tao France	27	1.1k 0.6×	756 0.6×	660 0.6×	1.0k 1.1×	91 0.2×	112	2.3k
Yeon‐Sil Kim South Korea	22	507 0.3×	454 0.4×	705 0.6×	546 0.6×	218 0.4×	110	1.6k
Panagiotis Balermpas Germany	23	463 0.2×	493 0.4×	566 0.5×	713 0.7×	307 0.6×	115	1.7k

Countries citing papers authored by Peter M.L. Teo

Since Specialization

Citations

This map shows the geographic impact of Peter M.L. Teo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M.L. Teo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M.L. Teo more than expected).

Fields of papers citing papers by Peter M.L. Teo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M.L. Teo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M.L. Teo. The network helps show where Peter M.L. Teo may publish in the future.

Co-authorship network of co-authors of Peter M.L. Teo

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M.L. Teo. A scholar is included among the top collaborators of Peter M.L. Teo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M.L. Teo. Peter M.L. Teo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, V., et al.. (2011). Dosimetric evaluation of a three-phase adaptive radiotherapy for nasopharyngeal carcinoma using helical tomotherapy. Medical dosimetry. 37(1). 92–97. 23 indexed citations

Ma, Brigette, et al.. (2008). A Novel Application of Plasma and Cerebrospinal Fluid Level of Epstein Barr Virus DNA in the Diagnosis of Leptomeningeal Metastasis from Nasopharyngeal Carcinoma. Oncology. 74(1-2). 119–122. 5 indexed citations

Kam, Michael K. M., Sing-Fai Leung, Benny Zee, et al.. (2007). Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients. Journal of Clinical Oncology. 25(31). 4873–4879. 544 indexed citations breakdown →

Teo, Peter M.L., Sing Fai Leung, Stewart Y. Tung, et al.. (2006). Dose–response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: A study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Radiotherapy and Oncology. 79(1). 27–33. 55 indexed citations

Teo, Peter M.L., Brigette Ma, & Anthony T.�C. Chan. (2004). Radiotherapy for nasopharyngeal carcinoma—transition from two-dimensional to three-dimensional methods. Radiotherapy and Oncology. 73(2). 163–172. 59 indexed citations

Chan, Anthony T.�C., Peter M.L. Teo, & Dolly P. Huang. (2004). Pathogenesis and treatment of nasopharyngeal carcinoma. Seminars in Oncology. 31(6). 794–801. 45 indexed citations

Kam, Michael, Peter M.L. Teo, Ricky Ming-chun Chau, et al.. (2004). Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experience. International Journal of Radiation Oncology*Biology*Physics. 60(5). 1440–1450. 415 indexed citations

Hui, Edwin P., Anthony T.�C. Chan, Francesco Pezzella, et al.. (2002). Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.. PubMed. 8(8). 2595–604. 263 indexed citations

Kwong, Joseph, Kwok Wai Lo, Ka‐Fai To, et al.. (2002). Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.. PubMed. 8(1). 131–7. 206 indexed citations

10.

Lee, Anne W.M., Dora L.�W. Kwong, Sing-Fai Leung, et al.. (2002). Factors affecting risk of symptomatic temporal lobe necrosis: significance of fractional dose and treatment time. International Journal of Radiation Oncology*Biology*Physics. 53(1). 75–85. 120 indexed citations

11.

To, Edward W.H., et al.. (2002). Nasopharyngectomy for Recurrent Nasopharyngeal Carcinoma: A Review of 31 Patients and Prognostic Factors. The Laryngoscope. 112(10). 1877–1882. 47 indexed citations

12.

Teo, Peter M.L. & Anthony T.�C. Chan. (2002). Treatment strategy and clinical experience. Seminars in Cancer Biology. 12(6). 497–504. 23 indexed citations

13.

Teo, Peter M.L., et al.. (2000). Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. International Journal of Radiation Oncology*Biology*Physics. 48(5). 1311–1322. 98 indexed citations

14.

Mok, Tony, et al.. (2000). Clinical outcomes of post-operative locoregional radiotherapy in pre-menopausal and post-menopausal Chinese women with breast cancer. Radiotherapy and Oncology. 54(3). 201–208. 5 indexed citations

15.

Teo, Peter M.L., et al.. (2000). Intracavitary brachytherapy significantly enhances local control of early T-stage nasopharyngeal carcinoma: the existence of a dose–tumor-control relationship above conventional tumoricidal dose. International Journal of Radiation Oncology*Biology*Physics. 46(2). 445–458. 80 indexed citations

16.

Cheung, K.Y., et al.. (1999). The roles of multileaf collimators and micro-multileaf collimators in conformal and conventional nasopharyngeal carcinoma radiotherapy treatments. Medical Physics. 26(10). 2077–2085. 12 indexed citations

17.

Teo, Peter M.L., et al.. (1999). Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. International Journal of Radiation Oncology*Biology*Physics. 43(2). 261–271. 46 indexed citations

18.

Chan, Anthony T.�C., Peter M.L. Teo, & Philip J. Johnson. (1998). Controversies in the management of locoregionally advanced nasopharyngeal carcinoma. Current Opinion in Oncology. 10(3). 219–225. 16 indexed citations

19.

Yeo, Winnie, Thomas Leung, S. F. Leung, et al.. (1996). Phase II study of the combination of carboplatin and 5-fluorouracil in metastatic nasopharyngeal carcinoma. Cancer Chemotherapy and Pharmacology. 38(5). 466–470. 37 indexed citations

20.

Teo, Peter M.L., et al.. (1991). A proposed modification of the Ho stage-classification for nasopharyngeal carcinoma. Radiotherapy and Oncology. 21(1). 11–23. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact